Thirty years ago, a farmer in China noticed two small painless nodules behind his ears, about the size of soybeans. They grew slowly enough that nobody rushed. By the time he reached 63, they were the size of eggs, matching each other with unsettling symmetry, and the skin over them had thickened and darkened.
Doctors had told him repeatedly it was benign lymphadenopathy. Nobody had ever taken a tissue sample.
One blood test told a different story. His eosinophils, immune cells that ordinarily make up under 9 percent of white blood cells, accounted for 38 percent of his.
Three Decades of a Diagnosis Nobody Confirmed
The case, published in January 2026 in Cureus by radiologists at Shandong Cancer Hospital and Institute in Jinan, documents what happens when a slow-growing mass gets a label instead of a workup.
He had received only intermittent symptomatic treatment across those decades, with no definitive evaluation and no tissue diagnosis. In the year before he finally presented, the itching over the lesions worsened, and the skin pigmentation deepened, which was what pushed him to seek care. Cosmetic concern, not pain, brought him in.
On examination, the left mass measured about 3.0 by 2.8 centimeters and the right 3.5 by 3.2. Both were soft, ill-defined, and non-tender. The overlying skin was lichenified and darkly pigmented, with no ulceration or warmth. He had no fever, no night sweats, no weight loss, and no history of autoimmune disease, cancer, or parasitic infection.
What the Scans Showed and Why It Looked Like Cancer
Contrast CT confirmed bilateral soft tissue masses behind both ears alongside enlarged lymph nodes on both sides of the neck. MRI added detail: bright on T2, intermediate to low on T1, with a heterogeneous texture the report likens to cotton wool.
The margins were poorly defined, blending into the adjacent parotid glands with no clean tissue plane. Multiple enlarged cervical nodes were present, the largest measuring about 1.8 centimeters across its short axis.
That combination, ill-defined masses invading tissue planes plus bilateral lymphadenopathy in an older man, reads like lymphoma. The clinicians kept malignancy high on their list.
The imaging pattern matched published descriptions of Kimura disease, a rare chronic inflammatory disorder. A retrospective case series in the Journal of Inflammation Research has catalogued the appearance: poorly demarcated subcutaneous masses with heterogeneous enhancement and T2 brightness, frequently with fat atrophy nearby. A systematic review in Current Problems in Diagnostic Radiology reached similar conclusions about the imaging signature.
Imaging narrowed the field. It could not close the case.
The Tissue Answered What Thirty Years of Watching Could Not
Surgeons removed both masses under general anesthesia and sampled the enlarged nodes. The lesions turned out to be poorly circumscribed lobulated masses inside the subcutaneous tissue, loosely stuck to the parotid glands but not invading them.
Under the microscope: prominent reactive lymphoid follicles with well-formed germinal centers, dense eosinophilic infiltration filling the spaces between them, and proliferating small postcapillary venules lined with plump endothelial cells. No cellular atypia. No lymphoma.
Those features also separated Kimura disease from angiolymphoid hyperplasia with eosinophilia, a condition it is routinely confused with, which shows more prominent vascular proliferation and less marked lymphoid follicle formation.
His absolute eosinophil count reached 5.29 billion per liter against a normal ceiling of 0.68, and his renal function and urinalysis came back normal with no protein in the urine. Serum IgE, often elevated in this condition, was not available at the initial workup, so the eosinophil count carried the diagnostic weight.
Kimura disease typically strikes young Asian men and usually appears on one side of the head or neck, though a head and neck review and a case series in Therapeutic Advances in Hematology both describe how easily it is mistaken for something worse. Bilateral symmetrical involvement is exceptionally uncommon, and a 63-year-old presentation sits far outside the age range usually described.
Surgery Plus Steroids, and a Recurrence Problem Nobody Has Solved
He received a short tapering course of oral prednisone after surgery, aimed at the eosinophil-driven inflammation that surgery alone leaves behind. At follow-up, his itching had resolved, the skin pigmentation had improved, and no new masses or enlarged nodes were found.
Surgery remains the primary treatment, but recurrence is common, which is why corticosteroids often follow. For cases that resist both, the authors point to newer options. Biologic drugs targeting the interleukin pathways that drive eosinophil activity have shown promise, including a case report in Frontiers in Immunology describing dupilumab combined with steroids for multisystem disease.
Imaging surveillance continues. The report describes good short-term control and states plainly that long-term follow-up remains necessary.
The broader point is not really about a rare disease. It is that a mass called benign for thirty years without a biopsy was never actually diagnosed, and one routine blood count pointed at the answer. Anyone with a persistent or enlarging neck mass should have it evaluated properly rather than accept reassurance indefinitely.
The study was approved by the ethics committee of Shandong Cancer Hospital and Institute. The authors reported no financial support and no relevant financial relationships.
Key Questions Answered
What is Kimura disease?
A rare chronic inflammatory disorder marked by painless subcutaneous masses in the head and neck, tissue and blood eosinophilia, and often elevated serum IgE. It is benign but persistent.
Why did this case take 30 years to diagnose?
He had been told elsewhere the lumps were benign lymphadenopathy and received only intermittent symptomatic treatment. No tissue sample was ever taken until this admission.
What made the diagnosis unusual?
Kimura disease typically appears in young Asian men on one side of the head or neck. This patient was 63 and had matching masses behind both ears, a presentation the authors call exceptionally uncommon.
What was the key clue?
Marked eosinophilia. His eosinophils made up 38 percent of his white blood cells, far above the normal ceiling of roughly 9 percent, which pointed toward an eosinophil-driven inflammatory process rather than lymphoma.
How was it treated?
Both masses were surgically removed and enlarged lymph nodes sampled. A short tapering course of oral prednisone followed to reduce inflammation and recurrence risk.
When should someone get a neck lump checked?
Any lump that persists, enlarges, or changes deserves medical evaluation. A lump described as benign without imaging or tissue confirmation has not actually been dia
